Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

CACI International To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday

Published 05/01/2024, 13:23
Updated 05/01/2024, 14:40
© Reuters.  CACI International To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday
CACI
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • Keybanc raised Invitation Homes Inc. (NYSE: INVH) price target from $35 to $38. Keybanc analyst Austin Wurschmidt maintained an Overweight rating. Invitation Homes shares fell 0.3% to close at $33.98 on Thursday. See how other analysts view this stock.
  • Needham boosted the price target for The Simply Good Foods Company (NASDAQ: SMPL) from $42 to $45. Needham analyst Matt McGinley maintained a Buy rating. Simply Good Foods shares gained 7.8% to close at $42.69 on Thursday. See how other analysts view this stock.
  • Raymond James raised the price target for Tradeweb Markets Inc. (NASDAQ: TW) from $94 to $102. Raymond James analyst Patrick O'Shaughnessy maintained an Outperform rating. Tradeweb Markets shares gained 6.9% to close at $95.10 on Thursday. See how other analysts view this stock.
  • Stifel increased CACI International Inc (NYSE: CACI) price target from $365 to $380. Stifel analyst Bert Subin upgraded the stock from Hold to Buy. CACI International shares fell 0.4% to close at $314.31 on Thursday. See how other analysts view this stock.
  • Morgan Stanley boosted the price target for Cytokinetics, Incorporated (NASDAQ: CYTK) from $60 to $90. Morgan Stanley analyst Jeffrey Hung downgraded the stock from Overweight to Equal-Weight. Cytokinetics shares rose 1.9% to close at $88.24 on Thursday. See how other analysts view this stock.
  • Jefferies increased the price target for Okta, Inc. (NASDAQ: OKTA) from $85 to $95. Jefferies analyst Brent Thill downgraded the stock from Buy to Hold. Okta shares fell 0.6% to close at $83.37 on Thursday. See how other analysts view this stock.
  • HC Wainwright & Co. cut Viracta Therapeutics, Inc. (NASDAQ: VIRX) price target from $10 to $4. HC Wainwright & Co. analyst Robert Burns maintained a Buy rating. Viracta Therapeutics shares gained 4.4% to close at $0.6054 on Thursday. See how other analysts view this stock.
  • Morgan Stanley cut CI&T Inc (NYSE: CINT) price target from $6 to $5.5. Morgan Stanley analyst Cesar Medina downgraded the stock from Overweight to Equal-Weight. > CI&T shares fell 0.4% to close at $5.06 on Thursday. See how other analysts view this stock.
  • Baird boosted Rexford Industrial Realty, Inc. (NYSE: REXR) price target from $53 to $61. Baird analyst David Rodgers downgraded the stock from Outperform to Neutral. Rexford Industrial Realty shares rose 0.1% to close at $55.21 on Thursday. See how other analysts view this stock.
  • Needham cut Mobileye Global Inc. (NASDAQ: MBLY) price target from $43 to $36. Needham analyst Quinn Bolton maintained a Buy rating. Mobileye Global shares fell 24.6% to close at $29.97 on Thursday. See how other analysts view this stock.

Check This Out: Retractable Technologies And 3 Other Stocks Under $3 Insiders Are Buying

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.